Professional Documents
Culture Documents
TO ANATOMY
ANALYZING PATIENTS
PROFILE FOR
OPTIMIZING CASE
CLERKING
THE UNIVERSITY OF
CHOICE
SCHOOL OF PHARMACY,
MSU
BPharm (Year 1)
BPharm (Year 2)
BPharm (Year 3)
BPharm (Year 4)
Attachments
EXAMPLE
Pharmacy Practice
Attachment
Pharmacy Practice
Attachment
Pharmacy Practice
Attachment
Pharmacy Practice
Attachment
Pharmacy Practice
Attachment
Pharmacy Practice
Attachment
Pharmacy Practice
Attachment
Pharmacy Practice
Attachment
Pharmacy Practice
Attachment
Pharmacy Practice
Attachment
Industrial Pharmacy
Attachment
Industrial Pharmacy
Attachment
ODAWARA KANEBO
R&D TECHNOLOGY DEPT.
Industrial Pharmacy
Attachment
Clinical Pharmacy
Attachment
Industrial Pharmacy
Attachment
Community Pharmacy
Attachment
Community Pharmacy
Attachment
Community Pharmacy
Attachment
Community Pharmacy
Attachment
Clinical Pharmacy
Attachment
Clinical Pharmacy
Attachment
Clinical Pharmacy
Attachment
Clinical Pharmacy
Attachment
Clinical Pharmacy
Attachment
Clinical Pharmacy
Attachment
Clinical Pharmacy
Attachment
Clinical Pharmacy
Attachment
Clinical Pharmacy
Attachment
CLINICAL ATTACHMENT
at Hospital Sungai Buloh
Takeshi Oshizaka
Josai University
Clinical Pharmacy
Attachment
Clinical Pharmacy
Attachment
Clinical Pharmacy
Attachment
OBJECTIVES (1)
OBJECTIVES (2)
1. TO LEARN PATIENTS
PROFILE (1)
Example (1)
The meaning and its implication of
patients
data on gender, age, weight, and
height.
PATIENTS DATA
Name : Mr. X
Sex : Male
Race : A
RN: 00.000.007
Height : 170 cm
Weight : 50 kg
Example
(1)
The meaning and its implication of
patients
data on gender, age, weight, and
height.
PATIENTS DATA
Name : Mrs. Y
Sex : Female
Race : B
RN: 00.000.008
Height : 156 cm
Weight : 82 kg
Example (1)
The meaning and its implication of
patients
data on gender, age, weight, and
height.
PATIENTS DATA
Name : Chd. Z
Sex : Male
Race : C
RN: 00.000.009
Height : 125 cm
Weight : 25 kg
Example (1)
Example
(1)
The meaning and its implication of
patients
data on gender, age, weight, and
height.
PATIENTS DATA
Name : Chd. Q
Sex : Female
Race : M
Age : 20 months
RN: 00.000.009
Height : 45 cm
Weight : 9.8 kg
Example (1)
1. TO LEARN PATIENTS
PROFILE (2)
Example (2)
PATIENTS DATA
Name : Mr. X
Sex : Male
Race : A
Age : 43 years
old
RN: 00.000.007
Height : 170 cm
Weight : 50 kg
CHIEF COMPLAINTS
FAMILY HISTORY
Father and brother have asthma
ALLERGY
NKDA
SOCIAL HISTORY
Smoker 10 cigarettes/day since age of 15
accessory
muscle of respiration, talking in full sentences.
GCS: Eye 4, Verbal 5, Motor 6, Total 15
CVS : BP (blood pressure) 132/62 mmHg
None
2. TO LEARN PATIENTS
DISEASE
The meaning of all results of
physical, laboratory and
radiology investigations, etc, on
the second day.
Units
Normal
range
Remark
s
Results
on 3/09
Renal profile
2.7
Normal
64-122
82
Normal
80-120
80
(indicated
)
Normal
Urea
mmol/L
1.7-8.3
SCr
umol/L
CrCl
ml/min
Electrolytes
Sodium
mmol/L
135-145
Potassiu
m
mmol/L
3.5-5.0
Calcium
mmol/L
2.142.58
n.a
Corrected mmol/L
calcium
2.142.58
n.a
Phosphat mmol/L
e
0.8-1.45
Magnesiu mmol/L
m
0.7-1.3
Chloride
mmol/L
96-106
141
Normal
7.7
High
n.a
n.a
107
High
x109/L
4.0-11.0
9.19
Normal
Hb
g/dL
11.515.5
14.5
Normal
RBC
x109/L
4.2-5.4
4.32
Normal
Hct
36.052.0
n.a
Plt
x109/L
150-400
n.a
Coagulation Profile
PT
second
s
10-13.5
n.a
APTT
second
s
26-42
n.a
<1.5
n.a
INR
Liver Profile
Total
Protein
g/L
Albumin
g/L
T.
Bilirubin
umol/L
ALT
IU/L
AST
IU/L
ALP
IU/L
66-87
70
Normal
35-50
37
Normal
<20
12
Normal
<32
14
Normal
n.a
53-141
54
Normal
Cardiac Profile
CK
Trop-T
IU/L
24-195
n.a
<0.1
n.a
LDH
IU/L
100-210
Lipid Profile
C- Total mmol/
<5.7
L
C- TG mmol/
<1.7
L
C- HDL mmol/
>1.7
L
C- LDL mmol/
<3.9
L
n.a
6.84
High
0.70
Normal
1.19
Slightly low
5.33
High
Value
37
37
Blood
Pressure
Pulse Rate
Respiratory
Rate
Norm
al
Value
Norm
al
108/7 105/5
9
8
62
112
20
Norm
al
Value
Value
03/0
9
02:3
3
04/0
9
02:5
4
108/7 119/6
9
3
62
60
20
04/0
9
15:4
5
108/7 103/7
9
1
62
75
21
3. TO LEARN TREATMENT
PROFILE
1. To learn progress note
2. To learn diagnose test
3. To learn treatment plan
Time
03/09 Plans:
02:33 Neb salbutamol 2 hourly, Neb Atovent Ventolin
Normal
saline 4hourly,
T predonisolone 30 mg od 5/7 (for 5 days)
Renal Profile, Liver function
BUSE BD review K + level to supplement K + if
<4
NP O2 3L/min
PEFR pre and post neb
MDI salbutamol 2 puffs pm, MDI budesonide 2
puffs BD
Pharmacist to assess MDI technique
Time
04/09 Progress:
02:54 Minimal SOB
Claim unable to sleep due to excessive sleeping
during day
time
Cough on and off
No fever
Plan:
Cont methadone 20 mg OD (in ward only)
To trace infectious screening HIV, hepatitis
screening
Refer to Selayang hepatologist for hep C upon
Time
04/09 Progress:
15:45 Comfortable
Speaks in full sentences
No SOB, wheezing, chest pain
No fever, Min cough, No abd pain
PEFR (Peak expiratory flow) 200 L/min
Plan:
Allow discharge
Cont MDI Salbutamol 2 puffs PRN and MDI
Budesonide 2
puffs
AFP, LFT, Hep C genotype
CURRENT MEDICATIONS
Date
Drug Regimen
Indication
Started
Stopped
03/09
05/09
To prevent inflammation
in the airways
03/09
05/09
To control inflammation
in the airways
03/09
05/09
Inhalation of Salbutamol
MDI 2 puffs (200 mcg), when necessary
Used as a bronchodilator
03/09
05/09
Used as a bronchodilator
03/09
05/09
03/09
05/09
To control elevated
cholesterol
Issues
Suggestion
Results
03/09
Patient is noncompliance to
budesonide
To counsel patient
with the stressed
on compliance
03/09
To suggest buying
aero chamber
03/09
Simvastatin has
adverse effects,
i.e.:
Rhabdomyolysis
, Hepatitis, and
Gastrointensitin
al tract
disturbance
To counsel patient
to be more alert of
these adverse
effects
03/09
Patient is
addicted to
heroin, he needs
to use
To counsel in how
important in using
methadone for him,
and how to use it.
Issues
Suggestion
Results
03/09
03/09
Patients has to
be prevented
from ADRs,
Drug
Interactions,
etc.
To monitor
Adverse effects
of Simvastatin,
i.e.:
Rhabdomyolysis,
Hepatitis, and
Gastrointensitinal
Tract disturbance
SUMMARY
1. Step ONE
1. REVIEWING PATIENT'S
MEDICAL CHARTS
REVIEWING PMR
Read PMR
and assess
the data
2. Step TWO
2. BUILDING A
PHARMACISTS PATIENT
DATA BASE
3. Step THREE
3. CONSTRUCTING A
PATIENT'S
DRUG THERAPY PROBLEM
LIST
4. Step FOUR
4. DESIGNING AND
RECOMMENDING A
PHARMACIST S CARE PLAN
5. Step FIVE
5. MONITORING
PHARMACISTS CARE
PLAN
MONITORING
Patients
interview
Physical examination
Steven Johnson's
Syndrome
Steven Johnson's
Syndrome
Red mans
syndrome
NaBic injeksi
CRITICAL APPRAISAL
CRITICAL APPRAISAL
CHECKLIST
BestBETs CA database
http://www.bestbets.org/cgi-bin/browse.pl?~show=appra
isal
HIERARCHY OF
EVIDENCE
SOURCES OF SYSTEMATIC
REVIEWS
The Cochrane Library www.library.nhs.uk
DARE (in Cochrane Library Other reviews)
Health Technology Assessments (in
Cochrane Library Technology Assessments)
Medline, Cinahl, Embase search on
systematic review in title, abstract
PubMed Systematic Review in Limits >
Topic
TRIP www.tripdatabase.com
Validity/Strength of Inference
CLINICAL PRACTICE
GUIDELINES (CPG)
Antibiotic Guidelines
Analgesic Guidelines
Respiratory Drugs Guidelines
Cardiology Drugs Guidelines
Endocrine Drugs Guidelines
Psychiatry Drugs Guidelines
Standard Operating Procedures
TERIMAKASIH